NCT05078970 Advancing Suicide Intervention Strategies for Teens During High Risk Periods
| NCT ID | NCT05078970 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seattle Children's Hospital |
| Condition | Suicide Attempts |
| Study Type | INTERVENTIONAL |
| Enrollment | 306 participants |
| Start Date | 2022-08-11 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 306 participants in total. It began in 2022-08-11 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To inform the effective management of adolescent suicide risk by evaluating promising treatments and developing the evidence-base for interventions that are well suited for widespread adoption, sustained quality, and impact.
Eligibility Criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Youth, aged 11-17 3. Endorse suicidal ideation and/or behavior 4. Admitted to acute care (emergency, inpatient medical or inpatient psychiatric) due to suicidality Exclusion Criteria: 1. Presence of psychosis, intellectual disability, autism spectrum disorder, eating disorder with unstable vitals 2. Limited English proficiency that would interfere with the ability to complete study assessments
Contact & Investigator
Molly Adrian
PRINCIPAL INVESTIGATOR
Seattle Childrens
Frequently Asked Questions
Who can join the NCT05078970 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 17 Years, studying Suicide Attempts. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05078970 currently recruiting?
Yes, NCT05078970 is actively recruiting participants. Contact the research team at molly.adrian@seattlechildrens.org for enrollment information.
Where is the NCT05078970 trial being conducted?
This trial is being conducted at Columbus, United States, Seattle, United States.
Who is sponsoring the NCT05078970 clinical trial?
NCT05078970 is sponsored by Seattle Children's Hospital. The principal investigator is Molly Adrian at Seattle Childrens. The trial plans to enroll 306 participants.